AU2013279748B2 - Conjugate of a photosensitiser and chitosan and uses thereof - Google Patents

Conjugate of a photosensitiser and chitosan and uses thereof Download PDF

Info

Publication number
AU2013279748B2
AU2013279748B2 AU2013279748A AU2013279748A AU2013279748B2 AU 2013279748 B2 AU2013279748 B2 AU 2013279748B2 AU 2013279748 A AU2013279748 A AU 2013279748A AU 2013279748 A AU2013279748 A AU 2013279748A AU 2013279748 B2 AU2013279748 B2 AU 2013279748B2
Authority
AU
Australia
Prior art keywords
compound
pct
cell
molecule
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013279748A
Other languages
English (en)
Other versions
AU2013279748A1 (en
Inventor
Kristian Berg
Vivek S. GAWARE
Anders Hogset
Mar Masson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PCI Biotech AS
Original Assignee
PCI Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PCI Biotech AS filed Critical PCI Biotech AS
Publication of AU2013279748A1 publication Critical patent/AU2013279748A1/en
Application granted granted Critical
Publication of AU2013279748B2 publication Critical patent/AU2013279748B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2013279748A 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof Ceased AU2013279748B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1208548.6A GB201208548D0 (en) 2012-05-15 2012-05-15 Compound and method
GB1208548.6 2012-05-15
PCT/EP2013/059968 WO2013189663A1 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof

Publications (2)

Publication Number Publication Date
AU2013279748A1 AU2013279748A1 (en) 2014-11-20
AU2013279748B2 true AU2013279748B2 (en) 2018-08-02

Family

ID=46458880

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013279748A Ceased AU2013279748B2 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof

Country Status (23)

Country Link
US (1) US9901636B2 (https=)
EP (1) EP2849791B1 (https=)
JP (1) JP6456284B2 (https=)
KR (2) KR102269861B1 (https=)
CN (1) CN104780941B (https=)
AU (1) AU2013279748B2 (https=)
BR (1) BR112014028315B1 (https=)
CA (1) CA2873259C (https=)
DK (1) DK2849791T3 (https=)
ES (1) ES2682762T3 (https=)
GB (1) GB201208548D0 (https=)
HR (1) HRP20181276T1 (https=)
HU (1) HUE039725T2 (https=)
IN (1) IN2014DN09418A (https=)
MX (1) MX362237B (https=)
NZ (1) NZ630582A (https=)
PL (1) PL2849791T3 (https=)
PT (1) PT2849791T (https=)
RU (1) RU2675830C2 (https=)
SG (1) SG11201407603YA (https=)
SI (1) SI2849791T1 (https=)
WO (1) WO2013189663A1 (https=)
ZA (1) ZA201408406B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
US10973896B2 (en) 2014-04-11 2021-04-13 Pci Biotech As Treatment or prevention of melanoma using photochemical internalization of a melanoma antigen
WO2016030529A1 (en) * 2014-08-28 2016-03-03 Pci Biotech As Compound and method
CN104650259A (zh) * 2015-01-23 2015-05-27 广西大学 一种纳米孔壳聚糖四(4-磺酸基苯基)金属卟啉微球及其制备方法和使用方法
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
GB201511159D0 (en) 2015-06-24 2015-08-05 Univ Nottingham Controlled cell delivery vehicle and treatment of tumours
EP3433422B1 (en) 2016-03-22 2020-11-18 Åbo Akademi University Polysaccharide derivatives as optical brightening agents
KR20190013289A (ko) * 2017-08-01 2019-02-11 순천대학교 산학협력단 수용성 키토산을 포함하는 나노광증감제
GB201801169D0 (en) 2018-01-24 2018-03-07 Pci Biotech As Method
CN108892743A (zh) * 2018-05-28 2018-11-27 南京工业大学 用于光动力抗菌的纳米光敏剂,其制备方法及应用
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
CN115399328B (zh) * 2021-05-27 2024-03-22 中国科学院化学研究所 一种多糖基杀菌材料及其制备方法和应用
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
CN117285662A (zh) * 2022-06-15 2023-12-26 南京仁为医药科技有限公司 一种壳聚糖双吡啶季铵盐及其制备方法
GB202301312D0 (en) 2023-01-30 2023-03-15 Pci Biotech As Method and product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996007432A1 (en) * 1994-09-08 1996-03-14 Radiumhospitalets Forskningsstiftelse Transfer of molecules into the cytosol of cells
WO2008130181A1 (en) * 2007-04-23 2008-10-30 Korea Institute Of Science And Technology Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
US20020022032A1 (en) 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
JP2002241307A (ja) * 2001-02-19 2002-08-28 Yasuhiko Tabata 光増感剤を含有する超音波治療用活性酸素発生剤
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
GB0415663D0 (en) 2004-07-13 2004-08-18 Psimei Pharmaceuticals Plc Compound
EP1888115A2 (en) 2005-05-16 2008-02-20 Universite De Geneve Compounds for photochemotherapy
JP4287411B2 (ja) * 2005-07-01 2009-07-01 株式会社東芝 仮想メモリシステムおよび仮想記憶方法
CN101024087A (zh) * 2007-03-28 2007-08-29 长沙理工大学 壳聚糖-多肽-卟啉纳米药物载体及其制备和应用
KR20090047872A (ko) 2007-11-08 2009-05-13 인제대학교 산학협력단 신규 카보하이드레이트 복합 클로린 화합물 및 이의제조방법
WO2009077908A1 (en) 2007-12-14 2009-06-25 University Of Lausanne Colloidal particle comprising multivalent cyclic anions
KR101076717B1 (ko) 2008-11-07 2011-10-26 재단법인대구경북과학기술원 광역학 치료용 나노구조체 및 그 제조방법
US20100129432A1 (en) 2008-11-25 2010-05-27 Taipei Medical University Microorganism-killing combination
KR100918811B1 (ko) 2009-04-29 2009-09-25 다이아텍코리아 주식회사 클로린 e6-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물
WO2010126179A1 (ko) 2009-04-29 2010-11-04 다이아텍코리아 주식회사 클로린 e6-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물
CN102573910B (zh) * 2009-06-12 2015-08-26 鹿特丹伊拉斯谟大学医疗中心 用于癌症光动力学治疗的靶向纳米光药物
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
KR101228106B1 (ko) 2010-01-21 2013-02-01 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
KR101250150B1 (ko) * 2010-10-29 2013-04-04 가톨릭대학교 산학협력단 광역학치료를 위한 고분자-광응답제 접합체 및 이의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996007432A1 (en) * 1994-09-08 1996-03-14 Radiumhospitalets Forskningsstiftelse Transfer of molecules into the cytosol of cells
WO2008130181A1 (en) * 2007-04-23 2008-10-30 Korea Institute Of Science And Technology Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy

Also Published As

Publication number Publication date
US20150202293A1 (en) 2015-07-23
JP6456284B2 (ja) 2019-01-23
BR112014028315A2 (pt) 2017-10-24
PL2849791T3 (pl) 2019-03-29
IN2014DN09418A (https=) 2015-07-17
EP2849791A1 (en) 2015-03-25
ZA201408406B (en) 2016-02-24
NZ630582A (en) 2017-02-24
CA2873259C (en) 2021-08-03
MX362237B (es) 2019-01-09
KR20150013803A (ko) 2015-02-05
HUE039725T2 (hu) 2019-01-28
ES2682762T3 (es) 2018-09-21
AU2013279748A1 (en) 2014-11-20
KR102269861B1 (ko) 2021-06-28
RU2675830C2 (ru) 2018-12-25
SG11201407603YA (en) 2014-12-30
EP2849791B1 (en) 2018-07-04
WO2013189663A1 (en) 2013-12-27
KR20200085380A (ko) 2020-07-14
HK1203850A1 (en) 2015-11-06
BR112014028315B1 (pt) 2022-02-22
HRP20181276T1 (hr) 2018-11-16
CA2873259A1 (en) 2013-12-27
DK2849791T3 (en) 2018-08-13
GB201208548D0 (en) 2012-06-27
CN104780941A (zh) 2015-07-15
SI2849791T1 (sl) 2018-10-30
PT2849791T (pt) 2018-10-04
JP2015516496A (ja) 2015-06-11
CN104780941B (zh) 2019-01-15
US9901636B2 (en) 2018-02-27
MX2014013516A (es) 2015-11-13
RU2014150569A (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
AU2013279748B2 (en) Conjugate of a photosensitiser and chitosan and uses thereof
Jiang et al. Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Wei et al. NIR-light triggered dual-cascade targeting core-shell nanoparticles enhanced photodynamic therapy and immunotherapy
Zhang et al. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy
Khandare et al. Novel polymeric prodrug with multivalent components for cancer therapy
Maruani et al. Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic
Wen et al. Utilizing viral nanoparticle/dendron hybrid conjugates in photodynamic therapy for dual delivery to macrophages and cancer cells
KR20220010525A (ko) 보론산 에스테르 전구약물 및 그의 용도
JPWO2005095494A1 (ja) 新規水溶性フラーレン、その製造方法およびそれを含む活性酸素発生剤
JP2015155442A (ja) 化合物及び生物学的材料並びにそれらの使用
Gaware et al. Endosome targeting meso-tetraphenylchlorin–chitosan nanoconjugates for photochemical internalization
Wu et al. Near-infrared light-initiated upconversion nanoplatform with tumor microenvironment responsiveness for improved photodynamic therapy
EP4077404A1 (en) Hyaluronic acid derivatives
CN116637185A (zh) 一种适用于肿瘤靶向光动力治疗的核酸适体偶联药物及其制备方法和用途
US10561730B2 (en) Plant virus particles for delivery of photosensitive agents
KR101138438B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
US20250304545A1 (en) Water-soluble heterocyclyl polymethine chromophores
JP2011518891A (ja) クロリンe6−葉酸結合化合物およびキトサンを含有する癌治療用薬学的組成物
HK1203850B (en) Conjugate of a photosensitiser and chitosan and uses thereof
KR101106756B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
KR101138437B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
KR102266865B1 (ko) 지방산을 유효성분으로 포함하는 수용성 광감작제 결합체 및 이의 제조방법
KR20120016573A (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
Fernandez-Megia Synthesis of multi-functional dendrimers for targeted delivery of nucleic acids

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired